Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 431 results.
User Information
Export Records
  1. 1.   Kaposi Sarcoma-Associated Herpesvirus Risk and Disease in Kidney Donors and Transplant Recipients with HIV in the United States
  2. Nambiar, Puja; Liang, Tao; Labo,Maria Nazzarena; Hand, Jonathan; Blumberg, Emily A; Rana, Meenakshi M; Florman, Sander; Haydel, Brandy; Morris, Michele I; Schaenman, Joanna; Rodrigues, Moreno M S; Werbel, William A; Bowring, Mary G; Friedman-Moraco, Rachel J; Stock, Peter; Stosor, Valentina; Mehta, Shikha; Gilbert, Alexander J; Elias, Nahel; Mehta, Sapna A; Small, Catherine B; Haidar, Ghady; Malinis, Maricar; Pereira, Marcus R; Aslam, Saima; Wojciechowski, David; La Hoz, Ricardo; Santos, Carlos A Q; Apewokin, Senu; Castillo-Lugo, Jose A; Ranganna, Karthik; Morsheimer, Megan; Massie, Allan; Segev, Dorry L; Miley,Wendell; Marshall,Vickie; Whitby,Denise; Tobian, Aaron A A; Durand, Christine M
  3. Clinical Infectious Diseases : an official publication of the Infectious Diseases Society of America. 2025, May 05;
  1. 2.   Prior SARS-Cov-2 infection affects adaptive immune responses to Omicron BA.4/BA.5 mRNA booster
  2. Wachter, Brianna T; Xu, Qin; Shi, Lihong; Burbelo, Peter D; Myint-Hpu, Kathy; Schwartzberg, Pamela L; Rehman,Tauseef; Dewar,Robin; Boswell, Kristin L; Koup, Richard A; Oguz, Cihan; Imberti, Luisa; Bellusci, Lorenza; Pourhashemi, Sara; Khurana, Surender; Manthiram, Kalpana; Notarangelo, Luigi D; Delmonte, Ottavia M
  3. The journal of Allergy and Clinical Immunology. . 2025, Mar 03;
  1. 3.   Isolation and structure elucidation of Dm-CVNH, a new cyanovirin-N homolog with activity against SARS-CoV-2 and HIV-1
  2. Orfanoudaki,Maria; Krumpe,Lauren; Shenoy, Shilpa R; Wilson,Jennifer; Guszczynski, Tad; Henrich,Curtis; Temme,Joel; Gildersleeve,Jeffrey; Molina-Molina, Elisa; Erkizia, Itziar; Blanco, Julià; Izquierdo-Useros, Nuria; Montiero, Fabio; Tanuri, Amilcar; Rech, Elibio; O'Keefe,Barry
  3. The Journal of Biological Chemistry. 2025, Feb 14; 108319.
  1. 4.   Viral Burden and Illness Severity During Acute SARS-CoV-2 Infection Predict Persistent Long COVID Symptoms
  2. Brandstetter Figueroa, Elisabeth; Frosch, Anne E P; Burrack, Kristina S; Dileepan, Gayathri; Goldsmith, Rachael; Harris, Morgan; Ikeogu, Nwando; Jibrell, Hodan; Thayalan, Sangeitha; Dewar,Robin; Shenoy, Chetan; Sereti, Irini; Baker, Jason V
  3. Open Forum Infectious Diseases. 2025, Feb; 12(2): ofaf048.
  1. 5.   Proteomic and serologic assessments of responses to mRNA-1273 and BNT162b2 vaccines in human recipient sera
  2. Hickey,Thomas; Mudunuri,Uma; Hempel,Heidi; Kemp,Troy; Roche,Nancy; Talsania, Keyur; Sellers, Brian A; Cherry, James M; Pinto,Ligia
  3. Frontiers in Immunology. 2025, Jan 27; 15: 1502458.
  1. 6.   Coronavirus Disease 2019 (COVID-19) Real World Data Infrastructure: A Big-Data Resource for Study of the Impact of COVID-19 in Patient Populations With Immunocompromising Conditions
  2. Crawford, James M; Penberthy, Lynne; Pinto,Ligia; Althoff, Keri N; Assimon, Magdalene M; Cohen, Oren; Gillim, Laura; Hammonds, Tracy L; Kapur, Shilpa; Kaufman, Harvey W; Kwasny, David; Liew, Jean W; Meyer, William A; Reynolds, Shannon L; Schleicher, Cheryl B; Subbiah, Suki; Theruviparampil, Catherine; Wallace, Zachary S; Warner, Jeremy L; Yoon, Suhyeon; Ziemba, Yonah C
  3. Open Forum Infectious Diseases. 2025, Jan; 12(1): ofaf021.
  1. 7.   A Novel Approach to Potentially Improving Soft-Tissue Sarcoma Survival: Prophylactic Lung Radiotherapy Inhibits Growth of Lung Metastases and Prolongs Survival in a Murine Soft-Tissue Sarcoma Model
  2. Ruditsky, Alexander; Fisher, Kalin; Tighe, Kayla; B'Lanton,Jasmine; Ma, Xinrong; Jiang, Kai; Byrne, Kevin; Carter-Cooper, Brandon; Casildo, Andrea; Passaniti, Antonino; Carrier, France; Lapidus, Rena; Richard, Katharina; Kallen, Michael E; Ng, Vincent Y
  3. Cureus. 2024, Dec; 16(12): e76334.
  1. 8.   Affinity Tag-Free Purification of SARS-CoV-2 N Protein and Its Crystal Structure in Complex with ssDNA
  2. Maiti,Atanu; Matsuo,Hiroshi
  3. Biomolecules. 2024, Nov 30; 14(12):
  1. 9.   Adjuvants to the S1-subunit of the SARS-CoV-2 spike protein vaccine improve antibody and T cell responses and surrogate neutralization in mice
  2. Becker, William; Rebbani, Khadija; Duan, Zhijian; Valkov,Eugene; Bryant, Shawn; Ho, Mitchell; Berzofsky, Jay A; Olkhanud, Purevdorj B
  3. Scientific Reports. 2024, Nov 28; 14(1): 29609.
  1. 10.   Analytical measuring interval, linearity, and precision of serology assays for detection of SARS-CoV-2 antibodies according to CLSI guidelines
  2. Haynesworth,Katrina; Kemp,Troy; Loftus,Sarah; Metz,Jordan; Castro, Nicholas C; Bullock, Jimmie; Fetterer, David; Pinto,Ligia
  3. mSphere. 2024, Oct 31; e0039324.
  1. 11.   Humoral Immunity Profiling to Pandemic and Bat-Derived Coronavirus Variants: A Geographical Comparison
  2. Fathi, Parinaz; Alfonso, Andrea Lucia; Yek, Christina; Putman, Zoe; Drew,Matt; Esposito,Dom; Zaidi, Irfan; Chea, Sophana; Ly, Sokna; Sath, Rathanak; Lon, Chanthap; Chea, Huch; Leang, Rithea; Huy, Rekol; Ly, Sovann; Seng, Heng; Tan, Chee Wah; Zhu, Feng; Wang, Lin-Fa; Oliveira, Fabiano; Sadtler, Kaitlyn; Manning, Jessica
  3. Advanced Science (Weinheim, Baden-Wurttemberg, Germany). 2024, Oct 29; e2403503.
  1. 12.   Factors affecting Kaposi's sarcoma-associated herpesvirus transmission in rural Ugandan households, a longitudinal study
  2. Sabourin, Katherine R; Marshall, Vickie A; Eaton, Will; Kimono, Beatrice; Mugisha, Joseph; Miley, Wendell J; Labo, Nazzarena; Samayoa-Reyes, Gabriela; Whitby, Denise; Rochford, Rosemary; Newton, Robert
  3. Infectious Agents and Cancer. 2024, Oct 03; 19(1): 49.
  1. 13.   SARS-CoV-2 RNA and nucleocapsid antigen are blood biomarkers associated with severe disease outcomes that improve in response to remdesivir
  2. Singh, Kanal; Rubenstein,Kevin; Callier,Viviane; Shaw-Saliba, Katy; Rupert,Adam; Dewar,Robin; Laverdure,Sylvain; Highbarger,Helene; Lallemand,Perrine; Huang, Meei-Li; Jerome, Keith R; Sampoleo, Reigran; Mills, Margaret G; Greninger, Alexander L; Juneja, Kavita; Porter, Danielle; Benson, Constance A; Dempsey, Walla; El Sahly, Hana M; Focht, Chris; Jilg, Nikolaus; Paules, Catharine I; Rapaka, Rekha R; Uyeki, Timothy M; Lane, H Clifford; Beigel, John; Dodd, Lori E
  3. The Journal of Infectious Diseases. 2024, Sep 23; 230(3): 624-634.
  1. 14.   Impact of baseline SARS-CoV-2 load in plasma and upper airways on the incidence of acute extrapulmonary complications of COVID-19: a multicentric, prospective, cohort study
  2. Jensen, Tomas O; Harper, Katrina; Gupta, Shaili; Liu, Sean T; Dharan, Nila J; Baker, Jason V; Pett, Sarah L; Shaw-Saliba, Kathryn; Esmail, Aliasgar; Ho, Minh Q; Almasri, Eyad; Dewar,Robin; Lundgren, Jens; Vock, David M
  3. Clinical Infectious Diseases : an official publication of the Infectious Diseases Society of America. 2024, Sep 13;
  1. 15.   Structural and virologic mechanism of the emergence of resistance to Mpro inhibitors in SARS-CoV-2
  2. Hattori, Shin-Ichiro; Bulut, Haydar; Hayashi, Hironori; Kishimoto, Naoki; Takamune, Nobutoki; Hasegawa, Kazuya; Furusawa, Yuri; Yamayoshi, Seiya; Murayama, Kazutaka; Tamamura, Hirokazu; Li,Mi; Wlodawer, Alexander; Kawaoka, Yoshihiro; Misumi, Shogo; Mitsuya, Hiroaki
  3. Proceedings of the National Academy of Sciences of the United States of America. 2024, Sep 10; 121(37): e2404175121.
  1. 16.   MoMo30 Binds to SARS-CoV-2 Spike Variants and Blocks Infection by SARS-CoV-2 Pseudovirus
  2. DeBarros, Kenya; Khan, Mahfuz; Coleman, Morgan; Bond, Vincent C; Floyd, Virginia; Gbodossou, Erick; Diop, Amad; Krumpe,Lauren; O'Keefe,Barry; Powell, Michael D
  3. Viruses. 2024, Sep 07; 16(9):
  1. 17.   Guanylate-binding protein 5 antagonizes viral glycoproteins independently of furin processing
  2. Veler,Hana; Lun, Cheng Man; Waheed,Abdul; Freed,Eric
  3. mBio. 2024, Aug 30; e0208624.
  1. 18.   The Impact of SIV-Induced Immunodeficiency on SARS-CoV-2 Disease, Viral Dynamics, and Antiviral Immune Response in a Nonhuman Primate Model of Coinfection
  2. Melton, Alexandra; Rowe, Lori A; Penney, Toni; Krzykwa, Clara; Goff, Kelly; Scheuermann, Sarah E; Melton, Hunter J; Williams, Kelsey; Golden, Nadia; Green, Kristyn Moore; Smith, Brandon; Russell-Lodrigue, Kasi; Dufour, Jason P; Doyle-Meyers, Lara A; Schiro, Faith; Aye, Pyone P; Lifson,Jeffrey; Beddingfield, Brandon J; Blair, Robert V; Bohm, Rudolf P; Kolls, Jay K; Rappaport, Jay; Hoxie, James A; Maness, Nicholas J
  3. Viruses. 2024, Jul 21; 16(7):
  1. 19.   Severe Acute Respiratory Syndrome Coronavirus 2 Plasma Antibody and Nucleocapsid Antigen Status Predict Outcomes in Outpatients With Coronavirus Disease 2019
  2. Jilg, Nikolaus; Giganti, Mark J; Chew, Kara W; Shaw-Saliba, Katy; Ritz, Justin; Moser, Carlee; Evering, Teresa H; Daar, Eric S; Eron, Joseph J; Currier, Judith S; Hughes, Michael D; Lane, H Cliff; Dewar,Robin; Smith, Davey M; Li, Jonathan Z
  3. Clinical Infectious diseases : an official publication of the Infectious Diseases Society of America. 2024, Jul 17;
  1. 20.   Recombinant OC43 SARS-CoV-2 spike replacement virus: An improved BSL-2 proxy virus for SARS-CoV-2 neutralization assays
  2. Hu, Zhe; López-Muñoz, Alberto Domingo; Kosik, Ivan; Li, Tiansheng; Callahan, Victoria; Brooks, Kelsie; Yee, Debra S; Holly, Jaroslav; Santos, Jefferson J S; Castro Brant,Ayslan; Johnson, Reed F; Takeda, Kazuyo; Zheng,Zhi-Ming; Brenchley, Jason M; Yewdell, Jonathan W; Fox, Julie M
  3. Proceedings of the National Academy of Sciences of the United States of America. 2024, Jul 16; 121(29): e2310421121.
  1. 21.   Longitudinal analysis of the lung proteome reveals persistent repair months after mild to moderate COVID-19
  2. Kanth, Shreya M; Huapaya, Julio A; Gairhe, Salina; Wang, Honghui; Tian, Xin; Demirkale, Cumhur Y; Hou, Chunyan; Ma, Junfeng; Kuhns,Doug; Fink,Dani; Malayeri, Ashkan; Turkbey, Evrim; Harmon, Stephanie A; Chen, Marcus Y; Regenold, David; Lynch, Nicolas F; Ramelli, Sabrina; Li, Willy; Krack, Janell; Kuruppu, Janaki; Lionakis, Michail S; Strich, Jeffrey R; Davey, Richard; Childs, Richard; Chertow, Daniel S; Kovacs, Joseph A; Parizi, Parizad Torabi-; Suffredini, Anthony F
  3. Cell Reports. Medicine. 2024, Jul 16; 5(7): 101642.
  1. 22.   Evaluation of the Therapeutic Potential of Sulfonyl Urea Derivatives as Soluble Epoxide Hydrolase (sEH) Inhibitors
  2. Kundu, Biswajit; Dvorácskó, Szabolcs; Basu, Abhishek; Pommerolle, Lenny; Kim, Kyu Ah; Wood, Casey M; Gibbs, Eve; Behee, Madeline; Tarasova,Nadya; Cinar, Resat; Iyer, Malliga R
  3. Molecules (Basel, Switzerland). 2024, Jun 26; 29(13):
  1. 23.   Longitudinal Assessment of BNT162b2- and mRNA-1273-Induced Anti-SARS-CoV-2 Spike IgG Levels and Avidity Following Three Doses of Vaccination
  2. Bullock,Jimmie; Hickey,Thomas; Kemp,Troy; Metz,Jordan; Loftus,Sarah; Haynesworth,Katrina; Castro, Nicholas; Luke,Brian; Lowy, Douglas R; Pinto,Ligia
  3. Vaccines. 2024, May 09; 12(5):
  1. 24.   Evasion of NKG2D-mediated cytotoxic immunity by sarbecoviruses
  2. Hartmann, Jordan A; Cardoso, Marcella R; Talarico, Maria Cecilia Ramiro; Kenney, Devin J; Leone, Madison R; Reese, Dagny C; Turcinovic, Jacquelyn; O'Connell, Aoife K; Gertje, Hans P; Marino, Caitlin; Ojeda, Pedro E; De Paula, Erich V; Orsi, Fernanda A; Velloso, Licio Augusto; Cafiero, Thomas R; Connor, John H; Ploss, Alexander; Hoelzemer, Angelique; Carrington,Mary; Barczak, Amy K; Crossland, Nicholas A; Douam, Florian; Boucau, Julie; Garcia-Beltran, Wilfredo F
  3. Cell. 2024, Apr 11;
  1. 25.   SARS-CoV-2 seroprevalence in vaccine-naïve participants from the Democratic Republic of Congo, Guinea, Liberia, and Mali
  2. Sylvain, Laverdure; Donatien, Kazadi; Kadidia, Kone; Viviane, Callier; Djeneba, Dabitao; Dehkontee, Dennis; Cherif, Haidara Mory; Sally, Hunsberger; Tshiani Mbaya,Olivier; Renee, Ridzon; Irini, Sereti; Katy, Shaw-Saliba
  3. International Journal of Infectious Diseases : IJID : official publication of the International Society for Infectious Diseases. 2024, Feb 26; 106985.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel